Cyberdyne Inc. · TSE:7779

Cyberdyne — H1 FY2025 Earnings Presentation

40 slides from Cyberdyne's earnings presentation, Nov 14, 2024

  1. Slide 1: CYBERDYNE 2025年3月期 中間決算説明資料

    2025 3 CYBERDYNE 2024 11 14

  2. Slide 2: CYBERDYNE

    CYBERDYNE

  3. Slide 3: FY2024 H1 Results Summary (IFRS)

    FY2024 2 ( H1) - (IFRS ) ※ RHG +144 ( +63 +81) 2,143 26 ( +13 69 +30) +39 (+1.9%) 79 ( 103 +24) RHG + 184 466 89 ( 25 64) 3 +14 +217 RD +108 + 819 215 CEJ 842 ( +293 - +1136 = 842) 35 12 ※ = – ( , )* ※ +1 33

  4. Slide 4: RHG Consolidated Results

    RHG (842: BAF) Lea ed ea ed on | SS SS SS BAVIIVE BRT-LAS aR RDR-AHRS moi (IFRS2E%#) % RD FEM WaHR (-IY%) se EME RA W-IID REM wseHIAE (II) we EMS BRAS (V-%) wae and 802 A236 (A28%) 444 A175 (A20%) A1311 2,104 A\1317 (A63%) = ee 946 A62 (A7%) 365 A170 (47%) A598 2,143 A497 (A23%) re AT9 45) +713 +39

  5. Slide 5: RHG Results by Region

    RHG AMER EMEA : Europe, the Middle East and Africa APAC : Asia-Pacific ※

  6. Slide 6: HAL Revenue Breakdown

    HAL ( ) Sr: BAR -EBR : 2024H1 (FE : 2023H1) HALFRI4 7 268 450 (Em) (261) (424) PIN=7 2M HALF RI 47 80 0 80 (REALE - MAAS) GEER) (79) (0) (79) 44 52 96 HALMRDS 17 ia a ae 51 43 95 Twa HALES 17 ica mh a 19 (0) 19 HALE 17 nS & ee TRS 39 0 39 PRES CLEA (63) o} (63) zott 4 13 54 (AcousticX, HALHMUR. WER)

  7. Slide 7: CYBERDYNE

    CYBERDYNE

  8. Slide 8: Society 5.0/5.1

    Society Society Society Society Society 5.0/5.1 1.0 2.0 3.0 4.0

  9. Slide 9: AI, IT and Cybernics Technology

    Okyk * Al Gybernics " ANSOIAZ Al Al . Oy bk +t dn—yas Al FIRST ImPACT SIP

  10. Slide 10: Product Lineup

    ite - SHO BL ellie BSRERS BIC T ! *fedical HAL Single Joint TAg + FU4IN— + 74 DAEs speed Toh ps Denibe product tha can HCPSHAT7/OY— sry io a Omy KER, ITER C< 'Y4NoODAER Fi PRR MTT $4K=7 28m + 9-7 <aam one ‘Bhe- MEsoOauen + ear patients i TERRE * Ais is rs BIOs SUBIC & SB BEI) t Hesse» AIEEE CHANEL Y

  11. Slide 11: SIP Program

    (SIP) 1) 2) ( ) HCPS ( ) 3) HCPS 4)

  12. Slide 12: Pre-Hospital Hospital Post-Hospital

    Pre-Hospital Hospital Post-Hospital

  13. Slide 13: Slide 13

  14. Slide 14: Slide 14

  15. Slide 15: Slide 15

  16. Slide 16: Biophotonics LED

    | BIOPHOTONIGS (CS WRINGHNE: LICHT OTHE LEE SeieNCESe Diseased Tissue

  17. Slide 17: Research Institution Collaborations

    4 19 ‘University of | je89 USC eer ee 2 HARVARD MEDICAL SCHOOL, 9 i IOWA STATES) Stanford MEDICINE Jouns Hore eer > # , 1B RICE UNIVERSITY etl, TU/e B=: Institut Langevin a

  18. Slide 18: CYBERDYNE

    CYBERDYNE

  19. Slide 19: / / /

    / / /

  20. Slide 20: Cyberdyne Malaysia HAL

    CYBERDYNE MALAYSIA HAL SDN. BHD. HAL PERKESO APAC

  21. Slide 21: International Conference on Cybernics HAL 2023

    INTERNATIONAL CONFERENCE on CYBERNICS HAL 2023

  22. Slide 22: Qereerorwe

    Qereerorwe

  23. Slide 23: SOCSO urged to build rehabilitation centres

    HAL 12 Socso urged to build three new rehabilitation centres in five years jemama,

  24. Slide 24: HAL50

    (5/23) HAL50 (65 ) Dr. Hafez Bin Hussain Steven Sim Chee Keong Steven Sim Chee Keong Khairul Dzaimee Bin Daub Dr. Mohammed Azman Bin Aziz Mohammed Group CEO

  25. Slide 25: Slide 25

  26. Slide 26: NTU Spotlight

    https://www.ntu.edu.tw/spotlight/2024/2301_20240918.html

  27. Slide 27: Cybernics & Neurobionics Summit 2024 INI

    Cybernics & Neurobionics Summit 2024 INI* * International Neuroscience Institute Dr. Madjid Samii ( ) - INI President Dr. Amir Samii ( ) - INI Vice President

  28. Slide 28: AGEVITY 2024 EU

    AGEVITY 2024 EU https://agevity.com/en/

  29. Slide 29: Slide 29

  30. Slide 30: CYBERNICX FUTURE

    Qereerorwe CYBERNICX FUTURE CYBERNICx FUTURE BELECEGE ADIM

  31. Slide 31: Cybernics & Neurobionics Summit 2024

    10 Cybernics & Neurobionics Summit 2024

  32. Slide 32: 11th Annual Brain Mapping Day US Congress

    11th Annual Brain Mapping Day US Congress Dr. Babak Kateb Society for Brain Mapping & Therapeutics Chairman

  33. Slide 33: Advances in the Treatment of Physical-Motor Disability

    “Advances in the Treatment of Physical-Motor Disability", HTLV National Academy of Medicine (

  34. Slide 34: EU EMEA APAC HTLV-1 HAM

    HTLV-1 HAM HTLV-1 HAM EU EMEA APAC

  35. Slide 35: HTLV-1 HAM

    2023/10 HTLV-1 HAM 2024/5 !! HTLV-1

  36. Slide 36: G-BA

    G-BA 2023/01 2023/03 2023/09 2024/11 CRO G-BA (Federal Joint Committee, ) §137e SGB V Trial Regulation: : G-BA CRO: (Contract Research Organization)

  37. Slide 37: 900

    900

  38. Slide 38: C-Startup

    Qoreerarne, Tamagawa Sky! SMNAATIVY YODOBASHI CAMERA Assembly Center Tonomac uBTIC

  39. Slide 39: Slide 39

  40. Slide 40: Slide 40

Cyberdyne — H1 FY2025 Earnings Presentation on 6ix